Ingrid Teige (Former)

1 – 10 of 13

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/infl-ite?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2021
Mark Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
Mattsson, Jenny ^LU ; Ekdahl, Ludvig ^LU ; Junghus, Fredrik ^LU ; Ajore, Ram ^LU ; Erlandsson, Eva ^LU ; Niroula, Abhishek ^LU ; Pertesi, Maroulio ^LU ; Frendéus, Björn ^LU ; Teige, Ingrid ^LU and Nilsson, Björn ^LU (2021) In Nature Communications 12. p.1-8
- Contribution to journal › Article
2018
Mark A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
Ljungars, A. ^LU ; Mårtensson, L. ^LU ; Mattsson, Jenny ^LU ; Kovacek, M. ^LU ; Sundberg, A. ; Tornberg, Ulla-Carin ; Jansson, B. ^LU ; Persson, N. ; Emruli, V. Kuci ^LU and Ek, S. ^LU , et al. (2018) In JCO Precision Oncology 2(1).
- Contribution to journal › Article
Mark Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function
Buchan, Sarah L. ; Dou, Lang ; Remer, Marcus ; Booth, Steven G. ; Dunn, Stuart N. ; Lai, Chester ; Semmrich, Monika ^LU ; Teige, Ingrid ^LU ; Mårtensson, Linda ^LU and Penfold, Christine A. , et al. (2018) In Immunity 49(5). p.958-970
- Contribution to journal › Article
2015
Mark A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.
Hansson, Markus ^LU ; Gimsing, Peter ; Badros, Ashraf Z ; Martinsson Niskanen, Titti ; Nahi, Hareth ; Offner, Fritz ; Salomo, Morten ; Sonesson, Elisabeth ; Mau-Sorensen, Morten and Stenberg, Yvonne , et al. (2015) In Clinical Cancer Research 21(12). p.2730-2736
- Contribution to journal › Article
Mark Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
Roghanian, Ali ; Teige, Ingrid ^LU ; Mårtensson, Linda ^LU ; Cox, Kerry L ; Kovacek, Mathilda ^LU ; Ljungars, Anne ; Mattson, Jenny ^LU ; Sundberg, Annika ; Vaughan, Andrew T and Shah, Vallari , et al. (2015) In Cancer Cell 27(4). p.473-488
- Contribution to journal › Article
2013
Mark A human icam-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.
Veitonmäki, Niina ; Hansson, Markus ^LU ; Zhan, Fenghuang ; Sundberg, Annika ; Löfstedt, Tobias ^LU ; Ljungars, Anne ; Li, Zhan-Chun ; Martinsson-Niskanen, Titti ; Zeng, Ming and Yang, Ye , et al. (2013) In Cancer Cell 23(4). p.502-515
- Contribution to journal › Article
2010
Mark Suppression of EAE by oral tolerance is independent of endogenous IFN-beta whereas treatment with recombinant IFN-beta ameliorates EAE.
Liu, Yawei ^LU ; Teige, Ingrid ^LU ; Ericsson, Ida ^LU ; Navikas, Vaidrius and Issazadeh, Shohreh ^LU (2010) In Immunology and Cell Biology 88. p.468-476
- Contribution to journal › Article
2006
Mark Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.
Liu, Yawei ^LU ; Teige, Ingrid ^LU ; Birnir, Bryndis ^LU and Issazadeh, Shohreh ^LU (2006) In Nature Medicine 12(5). p.518-525
- Contribution to journal › Article
Mark IFN-beta inhibits T cell activation capacity of central nervous system APCs.
Teige, Ingrid ^LU ; Liu, Yawei ^LU and Issazadeh, Shohreh ^LU (2006) In Journal of Immunology 177(6). p.3542-3553
- Contribution to journal › Article
2005
Mark Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice.
Matheu, Victor ^LU ; Treschow, Alexandra ^LU ; Teige, Ingrid ^LU ; Navikas, Vaidrius and Issazadeh, Shohreh ^LU (2005) In Respiratory Research 6(1). p.25-25
- Contribution to journal › Article

« previous
1
2
next »